leftspacer middlespacer rightspacer
Media Menu
Featured Material

MAPS Bulletin Summer 2014: Research Edition
Media > Recent and Archival
July 23, 2014

Boulder: 10th Subject Treated, Two More Subjects Enrolled

On July 6, 2014, the 10th subject was treated in our ongoing study of MDMA-assisted psychotherapy for PTSD in Boulder, Colorado. This subject was enrolled on June 13. The 11th subject was enrolled on July 23. This study will enroll 23 subjects with chronic, treatment-resistant PTSD from sexual assault, violent crime, war, or any other cause. We are currently preparing a new study amendment proposing greater variability in dosing options for subjects’ unblinded sessions, giving subjects randomly assigned to the medium dose (100 mg) condition the option of selecting either a medium or full (125 mg) dose for their third experimental session. “The Boulder study is at its halfway point and the results have been encouraging and significant," reports study Principal Investigator Marcela Ot’alora. "We have witnessed people change in ways they did not think possible. I am continuously amazed by our participants’ willingness to embark on a journey they know little about, while having their world disrupted and ultimately doing tremendous work.”

Back to MAPS in the Media

Give Our Veterans Hope
1 in 7 Iraq and Afghanistan veterans suffer from PTSD, in many cases leading to suicide. We owe it to our veterans to stop this epidemic.

Tell the Pentagon to fund MAPS' groundbreaking work to treat PTSD.